November/December 2014
Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition Interactions
March 02, 2015
Article
The American Journal of Pharmacy Benefits
This study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.
Self-Reported Plan Switching in Medicare Part D: 2006-2010
March 02, 2015
Article
The American Journal of Pharmacy Benefits
Less than one-fourth of Part D beneficiaries reported switching plans. Elderly beneficiaries who reported switching did not realize significant savings in prescription costs over nonswitchers.
Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome
February 14, 2015
Article
The American Journal of Pharmacy Benefits
While fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.
The Economics of Renoprotective Therapy in Advanced Diabetic Kidney Disease
February 06, 2015
Article
The American Journal of Pharmacy Benefits
A budget-impact model illustrates the economic outcomes associated with renoprotective therapy on privately insured patients with advanced kidney disease.
Improving Transitions of Care for Patients With Acute Coronary Syndromes: A Focus on the Role of the Health System and Community Pharmacists on Adherence
December 16, 2014
Article
The American Journal of Pharmacy Benefits
The intended audience for this activity consists of medical directors, pharmacy directors, pharmacy benefit managers, and other managed care professionals who are involved with the treatment of patients with acute coronary syndrome.
Evaluation of Dual Versus Triple Therapy for Hepatitis C
December 16, 2014
Article
The American Journal of Pharmacy Benefits
In this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.
Rheumatoid Arthritis and Joint Replacement: Impact of Biologics
December 16, 2014
Article
The American Journal of Pharmacy Benefits
Since the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.
Longitudinal Trends of Utilization, Cost, and Prevalence in Oncology
December 16, 2014
Article
The American Journal of Pharmacy Benefits
Annual rates of increase in oncology drug utilization, drug price, and plan spending are quantified and potential contributors are explored.
Making the 2016 Marketplace More Patient Focused
December 16, 2014
Article
The American Journal of Pharmacy Benefits
The time is now to develop a consensus on how patient needs, health plan sustainability, and government regulations intertwine to create a more patient-focused insurance marketplace.
The New Role of Specialty Medications
December 16, 2014
Article
The American Journal of Pharmacy Benefits